ArticleFrontiers in medicine2018
Evaluating Clinical Genome Sequence Analysis by Watson for Genomics.
Article in Frontiers in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review.BioMed research international · 2022Pooled it
- A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.Cancers · 2025Review
- Research on biomarkers using innovative artificial intelligence systems in breast cancer.International journal of clinical oncology · 2024Review
- Future direction of total neoadjuvant therapy for locally advanced rectal cancer.Nature reviews. Gastroenterology & hepatology · 2024Review
- Empowering precision medicine: regenerative AI in breast cancer.Frontiers in oncology · 2024Article
- Clinical reporting for personalized cancer genomics requires extensive access to subscription-only literature.Journal of the Medical Library Association : JMLA · 2023Article
- Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information.Experimental hematology & oncology · 2022Review
- A Study of the Recent Trends of Immunology: Key Challenges, Domains, Applications, Datasets, and Future Directions.Sensors (Basel, Switzerland) · 2021Review
- A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.NPJ precision oncology · 2021Article
- The application of artificial intelligence in lung cancer: a narrative review.Translational cancer research · 2021Review
- Comparative analysis of target gene exon sequencing by cognitive technology using a next generation sequencing platform in patients with lung cancer.Molecular and clinical oncology · 2021Article
- Predictive article recommendation using natural language processing and machine learning to support evidence updates in domain-specific knowledge graphs.JAMIA open · 2020Article
- Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.Cancer science · 2020Article
- A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing.Scientific reports · 2019Article
- Artificial Intelligence in Clinical Health Care Applications: Viewpoint.Interactive journal of medical research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.